Abstract
A fairly frequent problem is infection by the urogenital protozoan Trichomonas vaginalis. It is perhaps the most common clinically recognized sexually transmitted disease in the United States, with about 2.5 million new cases occurring annually. Approximately 180 million new cases occur each year worldwide [1]. The infection has a continuous endemic source, for as many as half of the female carriers are totally asymptomatic. Newer treatments have greatly improved therapy for this disease, but diagnosis and the detection of carriers remain significant challenges. Symptomatic or asymptomatic urethritis or vaginitis due to T. vaginalis is the usual scenario. The spectrum of symptoms associated with this disease is wide. Ultimately, the diagnosis is established by identifying the causative organisms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Krieger JN, Holmes KK, Spence MR, et al: Geographic variation among isolates of Trichomonas vaginalis: Demonstration of antigenic heterogenicity by using monoclonal antibodies and the indirect immunofluorescence technique. J Infect Dis 152(5):979–984, 1985.
Wisdom R, Dunlop EMC: Trichomoniasis: Study of the disease and its treatment in women and men. Br J Vener Dis 41:90–95, 1965.
Sweet RL: Importance of differential diagnosis in acute vaginitis. Am J Obstet Gynecol 152:7:921–923; 1985.
Jones JG, Yamauchi T, Lambert B: Trichomonas vaginalis infestation in sexually abused girls. AJDC 139:846–847, 1985.
Fouts AC, Kraus SJ: Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 141:137–142, 1980.
Alderete JF, Guillermo EG: Specific nature of Trichomonas vaginalis parasitism of host cell surfaces. Infect Immunol 50:701–703, 1985.
Gardner WA, Culberson DE, Bennett BD: Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110:430–432, 1986.
Wherton A, Honigberg BM: Structure of trichomonads as revealed by scanning electron microscopy. J Protozool 26:56–62, 1979.
Chang TH, Tsing SY, Tzeng S: Monoclonal antibodies against Trichomonas vaginalis. Hybridoma 5:43–51, 1986.
Connelly RJ, Torian BE, Stibbs HH: Identification of a surface antigen of Trichomonas vaginalis. Infect Immunol 49:270–214, 1985.
Wright RA, Judson FN: Relative and seasonal incidences of the sexually transmitted diseases: A two year statistical review. Br J Vener Dis 54:433–439, 1978.
Krieger JN: Urologic aspects of trichomoniasis. Invest Urol 18:411–418, 1981.
Dunlop EMC, Wisdom AR: Diagnosis and management of trichomoniasis in men and women. Br J Vener Dis 41:85–90, 1965.
Lossick JG: Treatment of Trichomonas vaginalis infections. Infect Dis 4(Suppl.):801–818, 1987.
U.S. Department of Health and Human Services: STD Treatment Guidelines 1985. Washington, D.C.: U.S. Government Printing Office, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Millikan, L.E. (1989). Trichomoniasis. In: Parish, L.C., Gschnait, F. (eds) Sexually Transmitted Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3528-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3528-6_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8142-9
Online ISBN: 978-1-4612-3528-6
eBook Packages: Springer Book Archive